Trend
โ
Key levels
โ
Latest news & SEC filings
No headlines in the last 90 days.
ยท Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for THRD.
Start Free Trial โValuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
5
Moat Score
NONE
1/9
Piotroski Score
19.7
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Insider trades, congress trades, institutional flows, and short interest โ updated daily with real-time alerts.
See All Smart Money Signals โRevenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
39.74%
FCF Growth YoY
-67.6%
Revenue Trend
UNKNOWN
SEPT's Trading AI has generated a free, downloadable PDF research report for Third Harmonic Bio, Inc. (THRD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days โTHRD last reported on Aug 14, 2025: EPS -$0.26 vs -$0.22 expected โ a miss of 18.2%.
THRD trades at a P/E of 9.4.
THRD does not currently pay a dividend.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.